Adolescent depression: An update and guide to clinical decision-making

Psychiatry

Volumn 6, Issue 9, 2009, Pages 17-31

  Cook, Mary N ^a,b   Peterson, John ^b,c   Sheldon, Christopher ^b,c  

^a CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Adolescent; Depression; Suicide; Treatment

Indexed keywords

ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; VENLAFAXINE;

ADOLESCENT; ADOLESCENT DISEASE; CHRONIC DISEASE; CLINICAL DECISION MAKING; CLINICAL FEATURE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; EARLY DIAGNOSIS; FUNCTIONAL DISEASE; HUMAN; MENTAL STRESS; PSYCHOTHERAPY; RECURRENT DISEASE; REVIEW; SUICIDAL BEHAVIOR;

EID: 77649208209     PISSN: 15505952     EISSN: 15555194     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. Lancet. 2007;37:851-858.
2. Donohue JM, Pincus HA. Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment. Pharmacoeconomics. 2007;25(1):7-24.
3. Anderson RN. Deaths: leading causes for 2000. Natl Vital Stat Rep. 2002;50:1-85.
4. Birmaher B, Ryan ND, Williamson DE et al. Childhood and adolescent depression: a review of the past ten years. Part I. J Am Acad Child Adolesc Psychiatry. 1996;35:1427-1439.
5. Lewinsohn PM, Rohde P, Klein DN, Seeley JR. Natural course of adolescent major depressive disorder: I. Continuity into young adulthood. J Am Acad Child Adolesc Psychiatry. 1999;38:56-63.
6. Clarke GN, Hawkins W, Murphy M, et al.Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of group cognitive intervention. J Am Acad Child Adolesc Psychiatry. 1995;34:312-321.
7. Nomura Y, Wickramaratne PJ, Warner V, et al. Family discord, parental depression, and psychopathology in offspring: ten-year follow-up. J Am Acad Child Adolesc Psychiatry. 2002;41:402-409.
8. Beardslee WR, Versage EM, Van de Velde P, et al. Preventing depression in children through resiliency promotion: the prevention intervention project. In: McMahon RJ, Peters R (eds). The Effects of Parental Dysfunction on Children. New York: Kluwer Academic/Plenum, 2003;71-86.
9. Clarke GN, Hornbrook M, Lynch F et al. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001;58:1127-1134.
10. Brent DA, Birmaher B, Kolko D, et al. Subsyndromal depression in adolescents after a brief psychotherapy trial: course and outcome. J Affect Disord. 2001;63:51-58.
11. Birmaher B, Arbelaez C, Brent D. Course and outcome of child and adolescent major depressive disorder. Child Adolesc Psychiatr Clin N Am. 2002;11:619-637.
12. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46:1503-1526.
13. Weissman MM, Wolk S, Wickramaratne P, et al. Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch Gen Psychiatry. 1999;56:794-801.
14. Weissman MM, Wolk S, Wickramaratne P, et al. Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch Gen Psychiatry. 1999;56:794-801.
15. Weissman MM, Wickramaratne P, Nomura Y, et al. Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry. 2005;62:29-36.
16. Weissman MM, Wickramaratne P, Nomura Y, et al. Offspring of depressed parents: 20 years later. Am J Psychiatry. 2006;163:1001-1008.
17. Seeley, JR, Stice, E, Rohde P. Screening for depression prevention: Identifying adolescent girls at high risk for future depression. J Abnormal Psychol. 2009;118:161-170.
18. Haskin BL. Cognitive vulnerability-stress model of depression during adolesecence: investigating depressive symptom specificity in a multiwave prospective study. J Abnorm Child Psychol. 2008;36:999-1014.
19. Fombonne E, Wostear G, Cooper V, et al. The Maudsley long-term follow-up of child and adolescent depression. 1. Psychiatric outcomes in adulthood. Br J Psychiatry. 2001;179-210.
20. Geller B, Fox LW, Clark KA (1994), Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12 year-old depressed children. J Am Acad Child Adolesc Psychiatry. 33:461-468.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, Text Revision. Washington, DC: American Psychiatric Press Inc., 2000.
22. World Health Organization. International Classification of Diseases, Tenth Revision. Geneva: World Health Organization, 1992.
23. Beautrais AL. Risk factors for suicide and attempted suicide among young people. Aust N Z Psychiatry. 2000;34:420-436.
24. Brent DA, Baugher M, Bridge J, et al. Age and sex-related risk factors for adolescent suicide. J Am Acad Child Adolesc Psychiatry. 1999;38:1497-1505.
25. Fergusson DM, Woodward LJ. Mental health, educational, and social role outcomes of adolescents with depression. Arch Gen Psychiatry. 2002;59:225-231.
26. Fergusson DM, Horwood LJ, Ridder EM, Beautrais AL. Subthreshold depression in adolescence and mental health outcomes in adulthood. Arch Gen Psychiatry. 2005;62:66-72.
27. Hammen C, Shih J, Altman T, Brennan PA. Interpersonal impairment and the prediction of depressive symptoms in adolescent children of depressed and nondepressed mothers. J Am Acad Child Adolesc Psychiatry. 2003;42:571-577.
28. Hammen C, Brennan PA, Shih JH. Family discord and stress predictors of depression and other disorders in adolescent children of depressed and nondepressed women. J Am Acad Child Adolesc Psychiatry. 2004;43:994-1002.
29. Harrington RC. Childhood depression and conduct disorder: different routes to the same outcome? Arch Gen Psychiatry. 2001;58:237-238.
30. Fergusson DM, Wanner B, Vitaro F, et al. Deviant peer affiliations and depression: confounding or causation. J Abnorm Child Psychol. 2003;31:605-618.
31. Lewinsohn PM, Clarke GN, Seeley JR, Rohde P. Major depression in community adolescents: age at onset, episode, duration and time to recurrence. J Am Acad Child Adolesc Psychiatry. 1994;33:809-818.
32. Fombonne E, Wostear G, Cooper V, et al. The Maudsley long-term follow-up of child and adolescent depression. 2. Suicidality, criminality and social dysfunction in adulthood. Br J Psychiatry. 2001;179:218-223.
33. Brent DA, Johnson B, Bartle S, et al. Personality disorder, tendency to impulsive violence, and suicidal behavior in adolescents. J Am Acad Child Adolesc Psychiatry. 1993;32:69-75.
34. Brent DA, Perper JA, Goldstein CE et al. Risk factors for adolescent suicide: a comparison of adolescent suicide victims with suicidal inpatients. Arch Gen Psychiatry. 1988;45:581-588.
35. Weissman MM, Wolk S, Goldstein RB, et al. Depressed adolescents grown up. JAMA. 1999;281:1707-1713,
36. Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009;48:721-729.
37. National Library of Medicine (NLM). DailyMed: current medication information. Dailymed: http://dailymed.nlm.nih.gov/dailymed/about.cfm. Accessed June 29, 2009.
38. US Food and Drug Administration. Summary minutes of the CDER Psychopharmacological Drugs Advisory Committee and the FDA Pediatric Advisory Committee. September 13-14, 2004. Online document at: www.fda.gov/ohrms/dockets/ ac/04/minutes/2004-4065M1-Final.pdf. Accessed September 15, 2009.
39. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebocontrolled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54:1031-1037.
40. Emslie GJ, Rush AJ, Weinberg WA, et al. Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depress Anxiety. 1998;7:32-39.
41. Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2002;41:1205-1215.
42. Emslie GJ, Wagner KD, Kutcher S, et al. Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2006;45(6):709-719.
43. Wagner KD. Pharmacotherapy for major depression in children and adolescents. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:819-826.
44. Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized, controlled trials. JAMA. 2003;290:1033-1041.
45. Emslie GJ, Findling RL, Yeung PP, et al. Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry. 2007;46:479-488.
46. TADS Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized, controlled trial. JAMA. 2004;292:807-820.
47. Domino ME, Foster EM, Vitiello B et al. Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial. J Am Acad Child Adolesc Psychiatry. 2009;48:711-720.
48. Emslie GJ, Heiligenstein JH, Hoog SL, et al. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 2004;43:1397-1405.
49. Kennard, BD, Emslie, GJ, Mayes TL, et al. Cognitive-behaviroal therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adoles Psychiatry. 2008;47:1395-1404.
50. Hammad TA. Results of the Analysis of Suicidality in Pediatric Trials of Newer Antidepressants. Psychopharmacology Drugs Advisory Committee and the Pediatric Advisory Committee, September 13-14, 2004. Online document at: www.fda.gov/ohrms/dockets/ac/04/minutes/2004-4065M1-Final.pdf. Access September 15, 2009.
51. The TADS Team. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64:1132-1144.
52. National Center for Health Statistics: Health, United States, 2006. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ nchs/data/hus/hus06.pdf#062. Accessed March 13, 2008.
53. Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry. 2003;60:978-982.
54. Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults. Arch Gen Psychiatry. 2006;8:865-872.
55. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63:332-339.
56. Isacsson G, Holmgren P, Ahlner J. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides. Acta Psychiatr Scand. 2005;111:286-290.
57. Gray D, Moskos M, Keller T. Utah Youth Suicide Study New Findings. Santa Fe, New Mexico. Annual Meeting of the American Association of Suicidology. April 23-26, 2003 (abstract).
58. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry. 2005;62:165-172.
59. Emslie GJ, Kratochvil C, Vitiello B, et al. Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry. 2006;45:1440-1455.
60. Valuck RJ, Libby AM, Sills MR, et al. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs. 2004;18:1119-1132.
61. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull. 2006;132:132-149.
62. Compton NS, March SJ, Brent D, et al. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry. 2004;43:930-959.